Evidence map›Paper›PMID 35372060›Full record

ArticleFrontiers in oncology2022

XGboost Prediction Model Based on 3.0T Diffusion Kurtosis Imaging Improves the Diagnostic Accuracy of MRI BiRADS 4 Masses.

Wan Tang, Han Zhou, Tianhong Quan, Xiaoyan Chen, Huanian Zhang, Yan Lin, Renhua Wu

Abstract read
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Wan TangRadiology Department, Second Affiliated Hospital of Shantou University Medical College, Shantou, China.
Han ZhouRadiology Department, Second Affiliated Hospital of Shantou University Medical College, Shantou, China.
Tianhong QuanDepartment of Electronic and information Engineering, College of Engineering, Shantou University, Shantou, China.
Xiaoyan ChenRadiology Department, Second Affiliated Hospital of Shantou University Medical College, Shantou, China.
Huanian ZhangRadiology Department, Second Affiliated Hospital of Shantou University Medical College, Shantou, China.
Yan LinRadiology Department, Second Affiliated Hospital of Shantou University Medical College, Shantou, China.
Renhua WuRadiology Department, Second Affiliated Hospital of Shantou University Medical College, Shantou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The malignant probability of MRI BiRADS 4 breast lesions ranges from 2% to 95%, leading to unnecessary biopsies. The purpose of this study was to construct an optimal XGboost prediction model through a combination of DKI independently or jointly with other MR imaging features and clinical characterization, which was expected to reduce false positive rate of MRI BiRADS 4 masses and improve the diagnosis efficiency of breast cancer. Methods: 120 patients with 158 breast lesions were enrolled. DKI, Diffusion-weighted Imaging (DWI), Proton Magnetic Resonance Spectroscopy ( Results: MK derived from DKI performed better for differentiating between malignant and benign lesions than ADC, MD, tCho, K Conclusions: DKI is promising for breast cancer diagnosis and prognostic factor assessment. An optimized XGboost model that included DKI, age, shape and menstrual status is effective in improving the diagnostic accuracy of BiRADS 4 masses.

Indexed as

BiRADS 4breast cancerdiffusion kurtosis imagingimaging markerXGboost model

Identifiers

PMID35372060
PMCPMC8968064

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.